BRIEF published on 06/07/2024 at 08:28, 2 years 5 months ago Assemblée générale mixte de Biophytis le 24 juin 2024 Actionnaires Biophytis Biotechnologie Assemblée Générale Vote
BRIEF published on 06/07/2024 at 08:28, 2 years 5 months ago Biophytis Announces Combined General Meeting on June 24, 2024 Shareholders Biophytis General Meeting Voting Agenda
REGULATED PRESS RELEASE published on 06/07/2024 at 08:23, 2 years 5 months ago Assemblée générale mixte du 24 juin 2024 Biophytis SA tiendra son Assemblée Générale Mixte le 24 juin 2024 à Paris. Les actionnaires sont encouragés à voter en amont. La société se concentre sur le développement de traitements pour les maladies liées à l'âge Assemblée Générale Mixte Biophytis SA Vote Actionnaires Traitements Maladies Liées À L'âge Développement Candidats Médicaments
REGULATED PRESS RELEASE published on 06/07/2024 at 08:23, 2 years 5 months ago Combined General Meeting of June 24, 2024 Biophytis SA to hold Combined General Meeting (CGM) on June 24, 2024 in Paris. Shareholders encouraged to vote in advance via multiple methods. Details available on the company's website Shareholders Voting Combined General Meeting Biophytis SA CGM
BRIEF published on 06/07/2024 at 07:44, 2 years 5 months ago Assemblée générale mixte de Biophytis prévue le 24 juin 2024 Actionnaires Biophytis Paris Assemblée Générale Vote
BRIEF published on 06/07/2024 at 07:44, 2 years 5 months ago Biophytis Combined General Meeting scheduled for June 24, 2024 Shareholders Biophytis Paris General Assembly Vote
PRESS RELEASE published on 06/07/2024 at 07:39, 2 years 5 months ago Assemblée générale mixte du 24 juin 2024 Biophytis tiendra son Assemblée Générale Mixte le 24 juin 2024 à Paris. Les actionnaires sont invités à voter en amont par différents moyens. Infos sur le site web de la société Actionnaires Biophytis Assemblée Générale Société De Biotechnologie Vote
PRESS RELEASE published on 06/07/2024 at 07:39, 2 years 5 months ago Combined General Meeting of June 24, 2024 Biophytis to hold Combined General Meeting (CGM) on June 24, 2024 at Sorbonne Université. Shareholders urged to vote in advance. Company specializes in age-related disease therapeutics Shareholders Biophytis Therapeutics Combined General Meeting Age-related Diseases
BRIEF published on 05/14/2024 at 07:05, 2 years 5 months ago Biophytis lance une étude clinique phase 2 pour traiter l'obésité Biophytis Étude Clinique Phase 2 BIO101 Obésité
BRIEF published on 05/14/2024 at 07:05, 2 years 5 months ago Biophytis Unveils Phase 2 OBA Clinical Study Design in Obesity Biophytis Obesity Treatment Clinical Trial BIO101 OBA Clinical Study
Published on 11/06/2026 at 22:15, 2 days 8 hours ago Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
Published on 11/06/2026 at 13:00, 2 days 18 hours ago Alaska Energy Metals Achieves High Extraction Rates of Metals from Hydromet Testing, Nikolai Nickel Project, Alaska
Published on 11/06/2026 at 12:30, 2 days 18 hours ago Relevant Gold Receives Expanded Drilling Approvals for the Lewiston Project in Wyoming
Published on 11/06/2026 at 12:30, 2 days 18 hours ago Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Published on 11/09/2026 at 07:00, 11 minutes ago Sandoz launches new semaglutide treatment option in Brazil, expanding patient access to GLP-1 medicine in key global market
Published on 11/09/2026 at 07:00, 11 minutes ago Cicor receives awards for two major defence programmes
Published on 11/09/2026 at 01:55, 5 hours 16 minutes ago EQS-Adhoc: NEXTDC Limited: Response to Statement by Goodman Group & Digital Realty
Published on 11/08/2026 at 12:10, 19 hours ago GSMA MWC26 Doha opens with call to align on global industry standards and close MENA's connectivity gap
Published on 11/08/2026 at 10:15, 20 hours 55 minutes ago 2026 China International Intelligent Communication Forum Held in Wuxi
Published on 11/09/2026 at 07:00, 11 minutes ago bioMérieux receives U.S. FDA 510(k) clearance for the latest versions of the BIOFIRE® FILMARRAY® Gastrointestinal Panels to enhance detection of gastrointestinal pathogens including norovirus
Published on 11/09/2026 at 07:00, 11 minutes ago BIOPHYTIS ANNOUNCES THE OPERATIONAL LAUNCH OF ITS JOINT VENTURE IN CHINA
Published on 11/09/2026 at 07:00, 11 minutes ago Biophytis annonce le démarrage opérationnel de sa co-entreprise en Chine
Published on 11/09/2026 at 07:00, 11 minutes ago bioMérieux obtient l’autorisation 510(k) de la FDA américaine pour les dernières versions des tests BIOFIRE® FILMARRAY® Gastrointestinal Panels afin d’optimiser la détection des pathogènes gastrointestinaux, dont le norovirus
Published on 11/06/2026 at 19:06, 2 days 12 hours ago ALTAREIT : DÉCLARATION MENSUELLE DES OPÉRATIONS RÉALISÉES PAR LA SOCIÉTÉ SUR SES PROPRES TITRES OCTOBRE 2026
